In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Click Therapeutics is well on its way to doing both – and in a sit down interview at the Informa Biotech Showcase in San ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

Sanofi has said it will press ahead with regulatory filings for atopic dermatitis (AD) candidate amlitelimab after reporting ...

The EVA for DHTs used by people with hip and knee osteoarthritis (PDF) recommends eight products, namely: GetUBetter; Good ...

"The addition of relacorilant to nab-paclitaxel, a trusted and effective chemotherapy, is positioned to become a new standard ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in obesity, with some also earmarked for two other programmes – an ...

DMHTs sit within a broader wave of digital health technologies, helping manage a range of issues such as asthma with smart ...

J&J is predicting 2026 revenues will be between $99.5 billion and $100.5 billion, up from just over $94 billion in 2025.

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

The WHO has been working over the past year to try to get the Trump administration to change course, and Director General ...